Most cancers Screening? There’s an ARK ETF for That

HomeETFs

Most cancers Screening? There’s an ARK ETF for That

Most cancers therapies and coverings are among the many largest markets within the broader biotechnology sector, and genomics is among the most pop



Most cancers therapies and coverings are among the many largest markets within the broader biotechnology sector, and genomics is among the most popular avenues for that publicity. Enter the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). Most cancers screening is among the many many quickly evolving genomics frontiers that ARKG offers publicity to. There’s large revenue potential in most cancers […] Learn extra at ETFtrends.com.



www.nasdaq.com